Leigh Baldwin & Co’s Pfizer PFE Stock Holding History

Leigh Baldwin & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Sell	19,135 -653	-3%	-$17.1K	0.25%	92
2026 Q1	$556K	Buy	19,788 +452	+2%	+$12K	0.36%	71
2025 Q4	$481K	Sell	19,336 -43,949	-69%	-$1.11M	0.32%	81
2025 Q3	$1.61M	Sell	63,285 -2,115	-3%	-$52.2K	0.91%	25
2025 Q2	$1.59M	Buy	65,400 +754	+1%	+$17.6K	1.04%	20
2025 Q1	$1.64M	Sell	64,646 -398	-0.6%	-$10.4K	1.32%	19
2024 Q4	$1.73M	Buy	+65,044	New	+$1.76M	1.46%	12

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Leigh Baldwin & Co's PFE Position: Q2 2026 in Review

Leigh Baldwin & Co reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $17.1K and leaving 19,135 shares worth $461K. The position accounts for 0.25% of the portfolio, ranked #92.

Leigh Baldwin & Co first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.73M in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Leigh Baldwin & Co held 19,135 shares of Pfizer worth $461K as of Q2 2026.
Leigh Baldwin & Co sold 653 Pfizer shares in Q2 2026, an estimated $17.1K.
Pfizer made up 0.25% of Leigh Baldwin & Co's portfolio in Q2 2026, its #92 holding.
Leigh Baldwin & Co first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Leigh Baldwin & Co's Pfizer position peaked at $1.73M in Q4 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.